Spotlight
Clinical
Video Series
News
Partners
CME/CE
Subscribe
Champions Biotechnology, Inc: Tumor Xenotransplantation
Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts� ("tumor xenograft") that is being developed by researchers at Champion.
Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts™ (“tumor xenograft”) that is being developed by researchers at Champion.
Related Videos
View All
Related Content
